Fischer Medical Ventures Ltd and its subsidiary Time Medical International Ventures (India) Private Limited have partnered with BluSim Tech Pte Ltd to transform elderly care on a global scale.
BluSim Tech Pte Ltd specializes in Ballistocardiography, a non-invasive method that measures body motion from each cardiac cycle’s blood ejection. Their product, BluSim Mat, uses advanced algorithms and AI to offer continuous, contactless monitoring of vital signs such as heart rate, respiration rate, sleep patterns, and bed position. This technology converts micro-vibrations into meaningful health data, providing early warnings for potential health issues without the need for wearable devices. Additionally, it integrates external sensors to monitor blood oxygen levels and body temperature.
Mr. Ravindran Govindan, Chairman and Managing Director of Fischer Medical Ventures Ltd., conveyed his excitement about the partnership, noting that the exclusive global rights to market BluSim Tech products represent a new era in healthcare technology. He emphasized the company’s commitment to investing in cutting-edge technologies with unmet needs, highlighting BluSim’s potential in the elder care sector.
Dr. Gokul M Chinnappan, CEO of BluSim Tech Pte Ltd, highlighted the transformative potential of their flagship product. He stressed that the collaboration with Fischer MVL would enable broader access to their innovative solutions, enhancing patient care and well-being across more healthcare facilities.